Top Cannabis Stocks for Traders This Week: Industry Stats and Technical Levels
The U.S. cannabis market continues to shift quickly as new states expand access and more consumers enter the legal marketplace. Investors are watching major multi-state operators closely, especially as competitive pressure increases. December often brings renewed attention to companies with strong retail footprints and improving financial performance. As the sector matures, companies with scale and discipline stand out. These firms can weather pricing pressure while still maintaining customer loyalty and stable revenue trends.
Furthermore, the push for federal reform continues to build. Traders now look for companies that can adapt and grow even during periods of regulatory uncertainty. Therefore, it is important to focus on operators with wide footprints, efficient operations, and solid brand recognition. These qualities often support long-term growth. With that in mind, the following companies represent three of the top U.S. marijuana stocks to watch in December 2025.
[Read More] 3 Canadian Marijuana Stocks To Watch In 2026 That Could See A Massive Run
Top U.S. Marijuana Stocks to Watch in December 2025
- Green Thumb Industries (OTC: GTBIF)
- Glass House Brands (OTC: GLASF)
- Cansortium Inc. (OTC: CNTMF)
Green Thumb Industries (GTBIF)
Green Thumb Industries is a leading U.S. cannabis operator with a strong brand presence and a growing retail network. The company is known for its vertically integrated structure, which allows it to control cultivation, manufacturing, and retail operations. As of 2025, Green Thumb operates more than 100 dispensaries across several major states. Its largest presence is in Illinois and Pennsylvania, where consumer demand remains strong. Additionally, the company continues to expand its store count through targeted growth strategies. Customers know Green Thumb for its popular branded products and its reliable shopping experience. The company focuses heavily on quality and consistency, which helps build long-term loyalty. Although the industry remains competitive, Green Thumb has shown the ability to adapt quickly. This flexibility keeps the company relevant as market conditions shift.
Financially, Green Thumb continues to deliver steady revenue growth and positive earnings. The company reported rising sales driven by both retail expansion and strong branded product performance. Gross margins improved slightly due to better production efficiencies. Moreover, Green Thumb posted positive net income, which sets it apart from many struggling operators. Cash flow from operations remained healthy, supporting ongoing investments in retail and cultivation. The company also showed discipline with expenses and prioritized long-term profitability. Investors appreciate this approach because it reduces operational risk. Pricing pressure continues across many markets, yet Green Thumb has managed these challenges through cost controls and branding strength. Overall, the company remains well-positioned as the cannabis sector evolves. Therefore, many traders consider GTBIF a top pick for December 2025.
[Read More] Ancillary Cannabis Stocks Poised for Growth Heading Into 2026
Glass House Brands (GLASF)
Glass House Brands has become a significant name in the West Coast cannabis market. The company is heavily focused on California, where it operates several large greenhouse cultivation sites. Glass House also owns multiple retail dispensaries throughout the state, and its footprint continues to grow. The company is known for producing high-quality flower at a large scale. Its cultivation capacity ranks among the largest in the country. This gives the company a strong advantage in a competitive wholesale environment. Glass House works to deliver premium products at competitive prices. This strategy has helped the company win market share in several important regions. Additionally, the company continues expanding its retail presence to strengthen distribution. Because of its size and efficiency, Glass House attracts significant investor attention.
Financial results for Glass House show improvement as the company increases production. Revenues have grown steadily, supported by both higher wholesale demand and expanding retail sales. The company has also worked to reduce its cost per pound, thereby improving margins. Operating expenses have remained stable even as volumes increase. Although profitability is still emerging, Glass House has shown meaningful progress. Cash flow trends continue to improve, which strengthens the company’s long-term outlook. The company has also focused on disciplined capital spending. This helps preserve resources while still supporting strategic expansion. Because California remains a challenging market, Glass House’s efficiency is a major advantage. Investors often view the company as a potential long-term leader due to its scale and production capabilities. Consequently, GLASF remains a stock worth watching in December 2025.
[Read More] These Marijuana Stocks Could Make You Money In 2026
Cansortium Inc. (CNTMF)
Cansortium Inc. is a growing U.S. cannabis operator with an intense concentration in Florida. The company operates dozens of medical dispensaries across the state and continues to expand into new markets. Its largest presence remains in Florida, where patient demand continues to increase. Cansortium focuses on offering consistent and affordable medical cannabis products. The company also maintains cultivation and processing operations that support its retail network. This vertical integration helps ensure a steady supply and quality control. Although smaller than several national operators, Cansortium has built a loyal customer base. It continues to open new dispensaries and develop new product lines. As a result, the company’s brand recognition has expanded meaningfully. Its disciplined growth strategy keeps it competitive within a crowded market.
Cansortium’s financial performance has strengthened as store openings and patient growth rise. Revenue has climbed year over year, supported by increasing retail sales. Margins have improved due to better operating efficiency and stronger production output. The company also reported improved cash flow and reduced operational losses. These trends help support future expansion while limiting financial risk. Cansortium has focused on managing expenses carefully and prioritizing profitable markets. This approach has helped stabilize earnings. The company continues to work on debt reduction and capital discipline. While the broader cannabis sector faces pricing pressure, Cansortium has shown steady growth through targeted investment. Therefore, many traders see CNTMF as an emerging opportunity for December 2025. Steady expansion and improving financials make it a compelling stock to watch.
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
